First Allied Advisory Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$1.91M Buy
17,387
+10,760
+162% +$1.2M 0.06% 306
2020
Q2
$701K Buy
6,627
+1,205
+22% +$124K 0.03% 550
2020
Q1
$484K Sell
5,422
-882
-14% -$83K 0.02% 602
2019
Q4
$627K Sell
6,304
-194
-3% -$18.3K 0.02% 631
2019
Q3
$576K Buy
6,498
+1,426
+28% +$124K 0.02% 637
2019
Q2
$419K Buy
5,072
+193
+4% +$15.1K 0.01% 740
2019
Q1
$389K Sell
4,879
-3,481
-42% -$274K 0.01% 756
2018
Q4
$633K Sell
8,360
-894
-10% -$69.8K 0.03% 538
2018
Q3
$739K Sell
9,254
-853
-8% -$64.5K 0.03% 569
2018
Q2
$714K Sell
10,107
-673
-6% -$48.4K 0.03% 556
2018
Q1
$752K Sell
10,780
-1,143
-10% -$79.2K 0.03% 534
2017
Q4
$825K Buy
11,923
+847
+8% +$57.1K 0.03% 498
2017
Q3
$750K Buy
11,076
+1,363
+14% +$86.1K 0.03% 489
2017
Q2
$663K Sell
9,713
-480
-5% -$31.3K 0.03% 532
2017
Q1
$666K Buy
10,193
+2,028
+25% +$118K 0.03% 497
2016
Q4
$446K Sell
8,165
-993
-11% -$56.4K 0.02% 623
2016
Q3
$602K Buy
9,158
+3,403
+59% +$222K 0.03% 504
2016
Q2
$343K Sell
5,755
-1,283
-18% -$74.5K 0.02% 690
2016
Q1
$397K Sell
7,038
-215
-3% -$12.9K 0.02% 631
2015
Q4
$488K Buy
7,253
+312
+4% +$20.5K 0.03% 586
2015
Q3
$443K Buy
6,941
+195
+3% +$12.8K 0.02% 593
2015
Q2
$430K Buy
6,746
+2,463
+58% +$169K 0.02% 667
2015
Q1
$292K Sell
4,283
-1,309
-23% -$91K 0.02% 791
2014
Q4
$392K Buy
5,592
+800
+17% +$57.3K 0.03% 615
2014
Q3
$342K Buy
+4,792
New +$351K 0.03% 669
2014
Q2
Sell
-5,737
Closed -$369K 1006
2014
Q1
$369K Sell
5,737
-38,023
-87% -$2.46M 0.03% 629
2013
Q4
$2.62M Sell
43,760
-49,668
-53% -$2.7M 0.21% 139
2013
Q3
$4.89M Buy
93,428
+32,382
+53% +$1.63M 0.28% 103
2013
Q2
$2.89M Buy
+61,046
New +$3.11M 0.23% 129

Other funds holding AZN